Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function-Reference-Cited by-同舟云学术

Contractile Defect Caused by Mutation in MYBPC3 Revealed under Conditions Optimized for Human PSC-Cardiomyocyte Function

Published:2015-10 Issue:4 Volume:13 Page:733-745
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Birket Matthew J.,Ribeiro Marcelo C.,Kosmidis Georgios,Ward Dorien,Leitoguinho Ana Rita,van de Pol Vera,Dambrot Cheryl,Devalla Harsha D.,Davis Richard P.,Mastroberardino Pier G.,Atsma Douwe E.,Passier Robert,Mummery Christine L.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference66 articles.

1. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands;Alders;Eur. Heart J.,2003

2. Human cardiomyocyte hypertrophy induced in vitro by gp130 stimulation;Ancey;Cardiovasc. Res.,2003

3. Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice;Barefield;J. Mol. Cell. Cardiol.,2015

4. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome;Bellin;EMBO J.,2013

5. Hypothyroidism as a risk factor for cardiovascular disease;Biondi;Endocrine,2004

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automatic motion estimation with applications to hiPSC-CMs;Biomedical Physics & Engineering Express;2024-09-05

2. Enhancing Maturation and Translatability of Human Pluripotent Stem Cell-Derived Cardiomyocytes through a Novel Medium Containing Acetyl-CoA Carboxylase 2 Inhibitor;Cells;2024-08-13

3. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation;Human Cell;2024-05-18

4. Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes;Cell Reports;2024-05

5. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction;Cell Reports Medicine;2024-05